Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-12

FDA Approved: RADICAVA ORS — Original Application (Shionogi Inc.)

View source ↗

Summary

The FDA approved RADICAVA ORS (edaravone) for use as an oral suspension under an Original Application by Shionogi Inc., adding an oral formulation to the RADICA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RADICAVA ORS (edaravone)

Snippet

ORIG AP for RADICAVA ORS (EDARAVONE)